Back to search

National and Kapodistrian University of Athens

Μελέτη της ρύθμισης της L-DOPA αποκαρβοξυλάσης

Abstract

dc:description

L-3,4-dihydroxyphenyl-alanine decarboxylase (L-Dopa decarboxylase, or DDC, EC 4.1.1.26) is the enzyme which catalyzes the decarboxylation of L-Dopa to dopamine. Until recently this enzyme was thought to be a rather unregulated molecule that is present is serotonergic and non serotonergic tissues, as well as peripheral organs, where the function of the enzyme is still largely unknown. Although the regulation of the DDC gene has been extensively studied at a transcriptional, post-transcriptional and translational level, the exact molecular mechanisms that govern its expression and regulation still remain under investigation. DDC has been implicated in many pathological conditions it is accepted that the enzyme’s regulatory mechanisms play an important role in Parkinson’s disease, cancer and schizophrenia. For all the above reasons, DDC constitutes subject of an extensive study at a biochemical, as well as molecular and developmental biology level. The aim of the present dissertation was the study of the regulation of L-Dopa decarboxylase.The first axis of the related experimental approaches was to study the regulation of DDC expression in human cancer cell lines of neural and non-neural origin. It was detected, for the first time, the expression of the neural and non-neural type full-length transcript of DDC, as well as the expression of the alternative protein isoform, Alt-DDC in SH-SY5Y (human neuroblastoma), HeLa (human cervical adenocarcinoma) and HTB-14 (human glioblastoma-astrocytoma) cells.In order to study the regulation of DDC expression, we investigated the cellular topology of the full-length DDC, the alternative isoform ALT-DDC and its endogenous inhibitor Annexin V in cell lines of neural and non-neural origin. Temperature-induced phase separation in the presence of the non-anionic detergent Triton X-114 led to the recovery of DDC, Alt-DDC and Annexin V protein molecules in all three separation phases in cell lines SH-SY5Y (human neuroblastoma), HTB-14 (human glioblastoma-astrocytoma) and HEK-293 (human embryonic kidney cells). The cellular topology heterogeneity of the molecules suggests that complex mechanisms are involved in the regulation of the expression of the full-length DDC and the alternative isoform Alt-DDC.Due to the localization of DDC and Alt-DDC in all separation phases in the studied cell lines, we proceeded to further investigation of this phenomenon by studying the possibility of DDC solubilization from membrane fraction in HEK-293 cells. Solubilization of membrane-associated DDC was observed in a pH and time-dependent manner and was affected by divalent cations and serine and cysteine protease inhibitors. Furthermore, our data indicated that only a portion of the membrane-associated DDC molecules were released into the soluble fraction, suggesting the involvement of a possible regulated mechanism in the enzymatic activity of the molecule. In order to study DDC expression and enzymatic activity regulation, we investigated the interactions of the enzyme with other molecules. Immunoprecipitation experiments under non-denaturating conditions resulted in the detection of possible interaction between DDC and the endogenous inhibitor Annexin V in the soluble fraction of human placenta, the neural origin cell line SH-SY5Y and the epithelial origin cell line HeLa.It was, also, found a possible interaction between the alternative isoform Alt-DDC and Annexin V in the soluble fraction of human placenta. Immunoprecipitation of DDC enzymatic activity by Annexin V in SH-SY5Y and PC12 (rat pheochromocytoma) cells enhances the likelihood of the two molecules interaction.The study of DDC inhibition by endogenous and chemical inhibitors is very important for understanding the enzyme regulation mechanism. For this reason, it was investigated the effect of chemical inhibitors of DDC enzymatic activity and endogenous inhibitor isolated from human serum in cell lines of non-neural origin, in the present work. It was found, for the first time, that carbidopa was cytotoxic to HeLa (cervical adenocarcinoma) and MCF7 (human breast adenocarcinoma) cells. Instead, the chemical inhibitor NSD-1015 and the endogenous inhibitor isolated from human blood serum had no cytotoxic effects against the specific cell lines. The fact that DDC has been proposed as a diagnostic marker of cancer cells of neuroendocrine origin and as an marker of the embryonic origin and the growth and differentiation rate of the tumor, indicates the importance of the regulatory molecules of DDC enzymatic activity in the development of future chemotherapeutic approaches. To further study the regulation phenomenon, we proceeded to the investigation of the interaction of DDC and ALT-DDC with Annexini V system in eukaryotic CHO cells (Chinese Hamster Ovary cells). These cells do not express dopamine transporters DAT and VMAT-2 and L-Dopa Decarboxylase-expressing CHO cells are used to model DA-producing neurons. Initially, the coding region of Annexin V was subcloned into the eukaryotic expression vector, pcDNA 3.1 +. The recombinant vectors with the coding regions of the full-length DDC, the alternative isoform Alt-DDC and the endogenous inhibitor Annexin V were transfected into CHO cells, through electroporation. DDC enzymatic activity experiments certified the involvement of Annexin V in the DDC enzymatic activity regulation and confirmed previous data from our laboratory supporting its inhibitory activity. Effect of the inhibitory molecules Annexin V and carbidopa on the DDC enzymatc activity in apoptotic cells, suggested that DDC enzymatic activity regulation is, possibly, involved in apoptotic phenomena.DDC has been implicated in many pathological conditions such as Parkinson’s disease, cancer and schizophrenia. L-Dopa decarboxylase does not seem to be directly related to the etiology of Parkinson’s disease, but it is accepted that the enzyme’s regulatory mechanisms play an important role in the treatment of this disease. For these reasons, the study of DDC regulation is of particular interest, because it could contribute to the development of new experimental approaches and ultimately of new pharmacological and therapeutic tools against neurodegenerative and neoplastic diseases.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chalatsa, Ioanna
  • Χαλατσά, Ιωάννα

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/37553

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chalatsa, Ioanna; Χαλατσά, Ιωάννα. Μελέτη της ρύθμισης της L-DOPA αποκαρβοξυλάσης. National and Kapodistrian University of Athens, 2012. http://hdl.handle.net/10442/hedi/37553